| __timestamp | Johnson & Johnson | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 8494000000 | 18516000 |
| Thursday, January 1, 2015 | 9046000000 | 34140000 |
| Friday, January 1, 2016 | 9095000000 | 51872000 |
| Sunday, January 1, 2017 | 10554000000 | 71772000 |
| Monday, January 1, 2018 | 10775000000 | 97501000 |
| Tuesday, January 1, 2019 | 11355000000 | 118590000 |
| Wednesday, January 1, 2020 | 12340000000 | 169802000 |
| Friday, January 1, 2021 | 14277000000 | 192507000 |
| Saturday, January 1, 2022 | 14135000000 | 199563000 |
| Sunday, January 1, 2023 | 15048000000 | 253598000 |
| Monday, January 1, 2024 | 17232000000 |
Igniting the spark of knowledge
In the competitive world of pharmaceuticals and biotechnology, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Johnson & Johnson and Xencor, Inc. have shown contrasting trajectories in their R&D investments. From 2014 to 2023, Johnson & Johnson's R&D expenses surged by approximately 77%, reflecting their commitment to maintaining a leading edge in the industry. In contrast, Xencor, Inc., a smaller player, increased its R&D spending by a staggering 1,270%, albeit from a much smaller base. This dramatic rise underscores Xencor's aggressive push to innovate and capture market share. While Johnson & Johnson's R&D budget dwarfs that of Xencor, the latter's rapid growth rate highlights its potential to disrupt the market. As we look to the future, these spending patterns may well dictate the next wave of breakthroughs in healthcare.
Johnson & Johnson vs Merck & Co., Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Who Prioritizes Innovation? R&D Spending Compared for Johnson & Johnson and Zoetis Inc.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Xencor, Inc.
R&D Insights: How Rhythm Pharmaceuticals, Inc. and Xencor, Inc. Allocate Funds
Comparing Innovation Spending: Vericel Corporation and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Soleno Therapeutics, Inc. and Xencor, Inc.
R&D Spending Showdown: Evotec SE vs Xencor, Inc.